HCV and People Who Inject Drugs | March 24, 2021
Date of Presentation: March 24, 2021
Dr. Jessica Gregg, Medical Director at DePaul Treatment Centers and lead ECHO faculty member, shares information on HCV in people who inject drugs, and medications used to treat opioid use disorder.
Dr. Jessica Gregg
Jessica Gregg, MD, PHD, is the Medical Director at DePaul Treatment Centers and an Associate Professor of Medicine at Oregon Health and Science University (OHSU). She received her undergraduate degree from Stanford University, her medical degree from the University of New Mexico, and her doctorate in medical anthropology from Emory University. She is board certified in internal medicine and addiction medicine. At OHSU, Dr. Gregg serves as the director of the university’s addiction medicine ECHO clinics, as associate program director for OHSU’s addiction medicine fellowship, and as medical director of the OHSU HRBR clinic, which providers low-barrier MAT to vulnerable adults. She also provides clinical care on IMPACT, OHSU’s inpatient addiction medical consult service.
Date added: March 24, 2021